Lv1
10 积分 2023-11-03 加入
Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer
24天前
已完结
Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction
24天前
已完结
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance)
1个月前
已完结
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study
2个月前
已关闭
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
2个月前
已完结
HAEMORRHAGIC SHOCK SECONDARY TO AORTO-ENTERIC FISTULA AFTER TREATMENT WITH BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER CASE REPORT AND REVIEW OF THE LITERATURE
3个月前
已关闭
Evaluation of clinical decision support systems in oncology: An updated systematic review
4个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4个月前
已完结
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
4个月前
已完结
BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203
4个月前
已完结
皖公网安备34019202002308
